stars 1 stars 2 stars 3

VolNera Bio is developing topical antimicrobial treatments for hard-to-treat infected wounds. Our lead technology, STAMPS, is being explored for chronic, surgical and veterinary wound infections where AMR, biofilms and treatment failure can limit current options. We welcome conversations with stakeholders across wound care, AMR, veterinary medicine, pharma partnering and therapeutic development.

Website http://volnerabio.com
Employees 2 (0 on RocketReach)
Industry Biotechnology Research

VolNera Bio Questions

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users